Market Place
Sourcing Support
Encoded Cuts 29% Workforce To Extend Cash, Advance R&D
13 Feb 2025 //
BIOSPACE
Encoded Therapeutics Updates on ETX101 for Dravet Syndrome
13 Feb 2025 //
BUSINESSWIRE
Encoded Presents Gene Therapy Data At ASGCT 2024
07 May 2024 //
BUSINESSWIRE
Encoded Announces UK CTA Approval for Gene Therapy Candidate ETX101
26 Feb 2024 //
BUSINESSWIRE
Encoded Therapeutics Announces US IND Clearance and Australian CTA Approval
06 Feb 2024 //
BUSINESSWIRE
Encoded lays off 10% of staff after back-to-back $100M+ rounds
14 Jun 2023 //
FIERCE BIOTECH
Encoded Therapeutics Addresses Common Source of Gene Therapy Toxicity
19 May 2023 //
BUSINESSWIRE
Encoded Tx: Genomic Medicine Yields Selective Expression Optimizes Gene Therapy
18 May 2022 //
BUSINESSWIRE
Encoded to Present Initial ENVISION Natural History Study Data
23 Nov 2021 //
FIRSTWORDPHARMA
Encoded Therapeutics Raises $135M to Advance Potential Dravet Gene Therapy
28 Jul 2020 //
DRAVETSYNDROMENEWS
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.